Sugi Predict

Sugi Predict / Compounds / SCHEMBL21992004

SCHEMBL21992004

SCHEMBL21992004

CCOC(=O)C(C)C(C)COc1ccc(C(=O)c2ccc(Cl)cc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 3/20 0.48
▸ LMNA P02545 3/20 0.46
▸ MAPK1 P28482 2/20 0.46
▸ CYP1A2 P05177 3/20 0.44
▸ KMT2A Q03164 3/20 0.43
▸ NPSR1 Q6W5P4 2/20 0.43
▸ PPARA Q07869 3/20 0.43
▸ MAPT P10636 3/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ ABCB11 O95342 2/20 0.43
▸ CYP3A4 P08684 2/20 0.43
▸ TSHR P16473 2/20 0.43
▸ HTR2A P28223 2/20 0.43
▸ PPARG P37231 2/20 0.43
▸ PMP22 Q01453 2/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ MAOB P27338 2/20 0.43
▸ USP2 O75604 1/20 0.43
▸ ADORA3 P0DMS8 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21991342 0.93 CYP1A2 (0.49) HPGDLMNAMAPK1CYP1A2KMT2A
SCHEMBL21992727 0.89 CYP1A2 (0.46) HPGDLMNAMAPK1CYP1A2KMT2A
SCHEMBL21991940 0.88 HPGD (0.53) HPGDLMNAMAPK1CYP1A2KMT2A
SCHEMBL21991340 0.87 LMNA (0.52) HPGDLMNAMAPK1CYP1A2KMT2A
SCHEMBL21991594 0.87 L3MBTL1 (0.52) LMNAMAPK1CYP1A2KMT2AMAPT
SCHEMBL21991981 0.86 MAOB (0.53) HPGDLMNAPPARAMAPTMAOB
SCHEMBL21992005 0.85 HPGD (0.51) HPGDLMNAMAPK1CYP1A2KMT2A
SCHEMBL21992608 0.81 HPGD (0.50) HPGDLMNAMAPK1CYP1A2KMT2A
SCHEMBL21991336 0.80 CYP1A2 (0.50) CYP1A2KMT2APPARAMEN1CYP3A4
SCHEMBL21991341 0.80 TSHR (0.45) LMNAMAPK1CYP1A2KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220409566-A1 CCL5 Inhibitors LAPKO INC, dba AFECTA PHARMACEUTICALS 2022-12-29 — — US disclosed
US-20220142961-A1 CCL5 Inhibitors LAPKO INC, dba AFECTA PHARMACEUTICALS 2022-05-12 — — US disclosed
US-11318111-B2 CCL5 inhibitors LAPKO INC (US) 2022-05-03 — — US disclosed
US-20210196665-A1 CCL5 Inhibitors AFECTA PHARMACEUTICALS, INC. (US) 2021-07-01 — — US disclosed
US-10940132-B2 CCL5 inhibitors AFECTA PHARMACEUTICALS, INC. (US) 2021-03-09 — — US disclosed
US-20200138766-A1 CCL5 INHIBITORS LAPKO INC. DBA AFECTA PHARMACEUTICALS 2020-05-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220142961-A1 CCL5 Inhibitors CCL5, CCL11, CCR5 HPGD 765/4885LMNA 4533/4885MAPK1 2490/4885
US-20200138766-A1 CCL5 INHIBITORS CCL5, CCL11, CCR5 HPGD 765/4885LMNA 4533/4885MAPK1 2490/4885
US-20210196665-A1 CCL5 Inhibitors CCL5, CCL11, CCR5 HPGD 765/4885LMNA 4533/4885MAPK1 2490/4885
US-10940132-B2 CCL5 inhibitors CCL5, CCL11, CCR5 HPGD 765/4885LMNA 4533/4885MAPK1 2490/4885
US-11318111-B2 CCL5 inhibitors CCL5, CCL11, CCR5 HPGD 765/4885LMNA 4533/4885MAPK1 2490/4885
US-20220409566-A1 CCL5 Inhibitors CCL5, CCL11, CCR5 HPGD 765/4885LMNA 4533/4885MAPK1 2490/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.